Written By: advantage - Date published: 11:18 am, February 7th, 2021 - 42 comments
No good citizen in their right mind would want to see democracy further eroded in the United States of America. Cold cash and mercantilist in all levels of political process have lowered – shall we say Trumped – how the United States is perceived internationally. President Biden set out his thoughts for the world to consider yesterday.
New Zealand is one of our closest friends and partners. The unbreakable bond we share was established when the first US Consul to New Zealand was on hand to witness the signing of the Treaty of Waitangi on February 6, 1840.”
In other words, perhaps, the coronavirus virus uses long-term infections as a mutational testing ground. While inside one person, they can try out all these different combinations of mutations and figure out, through trial and error, which ones are best at evading the immune system or helping the virus become more infectious.
Nothing new and textbook virus evolution. However, the leap to the last sentence is not and is not the most likely outcome, rather the opposite, in my opinion, and very poorly worded.
And this process is likely happening again right now, worldwide, in other immunocompromised patients. Eventually, these new variants could mutate again and create even more dangerous forms of the virus.
any evidence of
Or maybe you could point me in the right direction? Bit of a vaccine mystery
Ginny Andersen: How will domestic capability and manufacturing contribute to New Zealand accessing a vaccine?
Hon Dr MEGAN WOODS: New Zealand’s science and vaccine manufacturing sectors have an incredibly important role to play in ensuring New Zealanders get early access to a vaccine. Locally, the Vaccine Alliance Aotearoa New Zealand will receive $10 million to lead COVID-19 vaccine research through a vaccine development and evaluation platform. This will see the brightest minds from the Malaghan Institute of Medical Research, the University of Otago, and Victoria University of Wellington work together to support global efforts to develop vaccines that are safe and fit for purpose. BioCell will receive $3 million to upgrade its existing facilities so it’s in a position to scale up and support local and global vaccine manufacturing. Depending on the chosen vaccine, this could see u